Clinical Trials in Houston

Showing 10741-10760 of 15,366 trials

Gefitinib in Treating Patients With Recurrent or Progressive CNS Tumors

NCT00025675

RATIONALE: Biological therapies such as gefitinib may interfere with the growth of tumor cells and slow the growth of CNS tumors. PURPOSE: Phase II trial to study the effectiveness of gefitinib in treating patients who have recurrent or progressive CNS tumors.

Brain and Central Nervous System Tumors

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins105 participantsStarted Oct 2001

Los Angeles, California, United States • San Francisco, California, United States • Bethesda, Maryland, United States +9 more locations

COMPLETEDPhase 2< 1 mile

An Efficacy and Safety Study of Daratumumab in Patients With Multiple Myeloma Who Have Received at Least 3 Prior Lines of Therapy (Including a Proteasome Inhibitor [PI] and Immunomodulatory Drug [IMiD]) or Are Double Refractory to a PI and an IMiD

NCT01985126

The purpose of this study is to evaluate the efficacy and safety of 2 daratumumab treatment regimens in participants with multiple myeloma who have received at least 3 prior lines of therapy (including a proteasome inhibitor \[PI\] and immunomodulatory drug \[IMiD\]) or are double refractory to a PI and an IMiD.

Multiple Myeloma

Janssen Research & Development, LLC124 participantsStarted Sep 2013

Duarte, California, United States • Los Angeles, California, United States • Atlanta, Georgia, United States +20 more locations

Gefitinib in Treating Patients With Recurrent or Progressive CNS Tumors

An Efficacy and Safety Study of Daratumumab in Patients With Multiple Myeloma Who Have Received at Least 3 Prior Lines of Therapy (Including a Proteasome Inhibitor [PI] and Immunomodulatory Drug [IMiD]) or Are Double Refractory to a PI and an IMiD

Find Trials by Condition in Houston

Safety, Tolerability and Efficacy of ISIS-GCGRRx in Patients With Type 2 Diabetes

Intravenous Acetaminophen in Craniotomy

Evaluation of Etafilcon A Daily Disposable Lenses

Radiation Therapy With or Without Chemotherapy in Treating Patients With Anaplastic Oligodendroglioma

Evaluation of the Performance of Two Contact Lenses Compared to a Marketed Lens

Vistakon Investigational Multi-purpose Contact Lens Care Solution.

A Comparator Study of Fluticasone Propionate Nasal Spray Verses (vs) Cetirizine in the Treatment of Seasonal Allergic Rhinitis

Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccines GSK2654911A and GSK2654909A Administered to Adults 18 to 64 Years of Age

A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus

Follow-up Study to Evaluate the Safety and Immunogenicity of a HPV Vaccine (580299) in North America

Phase III Cat-PAD Study

A Phase III Study of Apixaban in Patients With Atrial Fibrillation

A Safety Study of Intravenous Pro-Netupitant and Palonosetron Combination for the Prevention of Nausea and Vomiting

Comparison of Two Daily Disposable Contact Lenses Over 1-week of Wear

A Study Evaluating the Safety and Pharmacokinetics of DMUC4064A in Participants With Platinum-Resistant Ovarian Cancer or Unresectable Pancreatic Cancer

Dispensing Evaluation of Subjective Comfort, Vision, and Handling of a New Lens Compared to a Marketed Lens

Acute Study to Collect Electrical Signals From the Heart Using a Special Lead

Dispensing Evaluation of Printed Etafilcon A With Polyvinylpyrrolidone (PVP)